Hooman Noorchashm
Research Professor and Co-Director, Amy J. Reed Medical Device Safety Collaborative
Education
Perelman School of Medicine at the University of Pennsylvania, PhD
Bio
Dr. Hooman Noorchashm, an internationally recognized medical device safety expert, joined the Northeastern University community in 2025 as a research professor. Dr. Noorchashm serves as co-director of the Amy J. Reed Medical Device Safety Collaborative, a joint initiative between Northeastern Law and Tufts University. Supported by a three-year grant from Arnold Ventures, the project analyzes data from tens of thousands of medical devices to identify safety risks and develop legal tools to address them.
Since 2013, Dr. Noorchashm has focused on public health advocacy, patient safety and medical ethics, with an emphasis on medical device regulation. He utilizes a rigorous academic-activist approach to identifying anecdotes of patient harm, medical device safety failure and healthcare fraud that are part of larger systemic public health hazards to American patients. Dr. Noorchashm has studied and called attention to several high-profile patient safety failures in the medical device regulatory system. His work has led to medical device recalls and changes in the standards of care that elucidate gaps or failures in the evidence-based approach to innovation in modern healthcare. He also serves as president of the nonprofit advocacy group Harmed Americans for Reform of Medical-Device Safety (HARMS) Corp.
Dr. Noorchashm holds MD and PhD degrees from the University of Pennsylvania's Perelman School of Medicine. He completed residency training in general and cardiothoracic surgery at the Hospital of the University of Pennsylvania and Harvard Medical School’s Brigham and Women's Hospital, respectively.
Selected Works
-
- “Establishing Medical Device Transparency at the FDA—A Public Database for Device Labels,” Journal of the American Medical Association (June 02, 2025).
- “Northeastern Law Faculty Affiliated with the Amy J. Reed Collaborative Petition FDA Over Off-Label Use of Robotic and VATS Devices for Treatment of Persistent Atrial Fibrillation in Elderly Patients,” (May 6, 2025).
- “Northeastern Law Faculty Affiliated with the Amy J. Reed Collaborative Petition FDA to Recall all Humacyte Symvess Products,” Northeastern Law News Announcement (April 10, 2025).
- “Northeastern Law and Tufts Medical Center to Establish Amy J. Reed Collaborative to Promote Medical Device Safety,” Northeastern Law News Announcement (December 23, 2024).
Hooman Noorchashm
Research Professor and Co-Director, Amy J. Reed Medical Device Safety Collaborative